FI833161A - Foerfarande foer framstaellning av guanidinderivat - Google Patents

Foerfarande foer framstaellning av guanidinderivat Download PDF

Info

Publication number
FI833161A
FI833161A FI833161A FI833161A FI833161A FI 833161 A FI833161 A FI 833161A FI 833161 A FI833161 A FI 833161A FI 833161 A FI833161 A FI 833161A FI 833161 A FI833161 A FI 833161A
Authority
FI
Finland
Prior art keywords
guanidinderivat
foerfarande foer
foer framstaellning
appropriate
framstaellning
Prior art date
Application number
FI833161A
Other languages
English (en)
Other versions
FI833161A0 (fi
Inventor
Neil James Hales
Derrick Michael Mant
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI833161A0 publication Critical patent/FI833161A0/fi
Publication of FI833161A publication Critical patent/FI833161A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
FI833161A 1982-09-07 1983-09-05 Foerfarande foer framstaellning av guanidinderivat FI833161A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225509 1982-09-07

Publications (2)

Publication Number Publication Date
FI833161A0 FI833161A0 (fi) 1983-09-05
FI833161A true FI833161A (fi) 1984-03-08

Family

ID=10532749

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833161A FI833161A (fi) 1982-09-07 1983-09-05 Foerfarande foer framstaellning av guanidinderivat

Country Status (13)

Country Link
EP (1) EP0105590B1 (fi)
JP (1) JPS59134781A (fi)
AT (1) ATE24492T1 (fi)
DD (1) DD216011A5 (fi)
DE (1) DE3368612D1 (fi)
DK (1) DK367783A (fi)
ES (2) ES525445A0 (fi)
FI (1) FI833161A (fi)
GB (1) GB8316779D0 (fi)
GR (1) GR81302B (fi)
NO (1) NO833179L (fi)
PT (1) PT77263B (fi)
SU (1) SU1303027A3 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8401751D0 (en) * 1984-01-24 1984-02-29 Ici Plc Guanidine derivatives
JP4746528B2 (ja) * 2006-12-06 2011-08-10 株式会社マスカワ ガスケット
JP2011099631A (ja) 2009-11-06 2011-05-19 Denso Corp 熱交換器
CA2816983A1 (en) 2010-11-05 2012-05-10 Senomyx, Inc. Compounds useful as modulators of trpm8
BR112018006471B1 (pt) 2015-10-01 2024-02-27 Senomyx, Inc Composto, composição, método de modular o membro de melastina do canal potencial do receptor transitório 8 (trpm8), método de modular a sensação de resfrescância de uma composição e método de induzir uma sensação de refrescância em um ser humano ou animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
IN158869B (fi) * 1981-03-18 1987-02-07 Ici Plc

Also Published As

Publication number Publication date
ATE24492T1 (de) 1987-01-15
ES8507101A1 (es) 1985-08-16
GR81302B (fi) 1984-12-11
EP0105590B1 (en) 1986-12-30
ES8602624A1 (es) 1985-12-01
ES541830A0 (es) 1985-12-01
PT77263B (en) 1986-02-04
SU1303027A3 (ru) 1987-04-07
DK367783D0 (da) 1983-08-12
JPS59134781A (ja) 1984-08-02
DK367783A (da) 1984-03-08
ES525445A0 (es) 1985-08-16
EP0105590A1 (en) 1984-04-18
FI833161A0 (fi) 1983-09-05
DD216011A5 (de) 1984-11-28
PT77263A (en) 1983-09-01
GB8316779D0 (en) 1983-07-27
NO833179L (no) 1984-03-08
DE3368612D1 (en) 1987-02-05

Similar Documents

Publication Publication Date Title
HUT39151A (en) Process for production of diaril acetilens
DE3373653D1 (de) N-arylsulfonyl-n'-pyrimidinyl ureas
BG33886A3 (en) Method for heterocyclic compounds producing
FI891003A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-substituoitujen purinyylipiperatsiinijohdannaisten valmistamiseksi
BG42004A3 (en) Method for preparing pyridyl compounds
FI833161A0 (fi) Foerfarande foer framstaellning av guanidinderivat
ZA795893B (en) Process for the manufacture of 1,2,3-thiadiazol-5-yl ureas
ES8501771A1 (es) Procedimiento para la preparacion de un nuevo compuesto heterociclico
BG37225A3 (en) Method for preparing ammonia salts of substituted carbonic acid
NO157099C (no) FremgangsmŸte for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater.
BG35045A3 (en) Method for preparing substituted triarylthiazolic compounds
BG38337A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
GB1554493A (en) Process for the production of 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyramidine
IT1149846B (it) Processo per la sintesi di 1-ammino-3-p(b-metossi-etil)-fenosi-2-propanolo
YU4483A (en) Process for obtaining 6-aminopenicillanic acid 1,1-dioxides and derivatives thereof
BG36345A3 (en) Method for preparing cyclopentenic derivatives
DK435384A (da) L-argininisoxicamat
HUT34963A (en) Process for the production of 3,5 diamino-1,2,4-triazole-derivatives
BG42001A3 (en) Method for preparing of 1- aryl- 2- aminoethanol derivatives
RO86214A2 (ro) Procedeu de purificare a solutiei de 0,0-dimetil-s-(1,2-dicarbeto0ietil)-ditiofosfat tehnic
EP0248334A3 (en) Process for the manufacture of 2-nitro-4-sulfamyl-diphenyl amine dyes
BG37524A3 (en) Method for preparing 1, 5- benzothiazepines derivatives
PL234549A1 (en) Process for preparing n 4 upwards-substituted derivatives of tetrahydro-1,2,4-oxadiyzin-5-one
IT1184132B (it) Procedimento e macchina per la sfioccatura di tessuto a pelo
IL87733A (en) Process for the manufacture of 1,3-dioxane derivatives

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC